On 14 October, Director Claire Chunying Xie will participate in the Pharma Law USA conference. Dr. Xie will speak in the “Antitrust Challenges in the Pharma Sector” panel, exploring topics such as updates to the FTC’s and DOJ’s recent policies impacting the pharmaceuticals sector; pricing from an antitrust perspective, including PBM scrutiny; and practical tips for corporations to navigate the risks of drug pricing regulations.